From: Atypical fetal junctional ectopic tachycardia: a case report and literature review
Patients | |||||||||
---|---|---|---|---|---|---|---|---|---|
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | |
Age (years) | 32 | 23 | 27 | 34 | 25 | ||||
GA at examination (weeks) | 32 | 20 | 31 | 19 | 28 | 34 | 23 | 32 | 32 |
FHR (bpm) | 130 | 180 | 190 | 200 | 280 | 270 | 180 | 200 | 170 |
1:1 AV conduction | + | + | + | + | + | + | + | ||
AV dissociation | + | – | + | + | + | ||||
Minimal variability | + | + | |||||||
DV and PV retrograde flow | + | + | + | + | |||||
Fetal hydrops | – | + | + | + | + | + | + | + | |
Other findings | UV pulsation TR MR | Ventricular filling: monophasic | Ventricular filling: monophasic | UV pulsation | |||||
Ventricular filling: biphasic–monophasic | Dilated RA | ||||||||
Fetal ascites | fMCG: AV dissociation | TR | |||||||
FO abnormally displaced toward the right | |||||||||
Fetal diagnosis | PRFO | JET | JET or VT | JET | JET | JET | JET | JET | JET |
Fetal therapy | |||||||||
Digoxin | – | + (non-effective) | + (effective) | + (non-effective) | + | + (non-effective) | |||
Sotalol | – | + (non-effective) | + (non-effective) | + | + (non-effective) | ||||
Amiodarone | – | + (effective) | + (effective) | + (effective) | |||||
Flecainide | + (effective) | ||||||||
GA at delivery | 32 | 38 | 37 | 36 | 39 | 36 | 34 | ||
ECG | |||||||||
HR | 150–250 | 150–170 | 343 | 160 | |||||
1:1 AV conduction | + | + | |||||||
AV dissociation | + | + | + | ||||||
Neonatal therapy | |||||||||
Amiodarone | + (stopped because of side effect) | – | + (effective) | + (effective) | + (effective) | ||||
Flecainide | + (effective) | + (effective) | |||||||
Propranolol | + (effective) | + (effective) | |||||||
Prognosis | JET under control | Sinus rhythm | JET under control | Sinus rhythm | Stop postnatally | Stop prenatally | Sinus rhythm | JET under control |